| 7.26 Delayed Data As of 6:30pm ET |  -0.19 / -2.55%Today’s Change | 6.07 Today|||52-Week Range 25.13 | -52.92% Year-to-Date |
| BeiGene's NDA for Zanubrutinib Gets Priority Review From FDA 11:08am / Zacks.com - Paid Partner Content | Warren Buffett's Portfolio Yields a Big Surprise Aug 20 / MotleyFool.com - Paid Partner Content |
| Mallinckrodt (MNK) Stock Down 70.8% YTD on Numerous Lawsuits 7:42am / Zacks.com - Paid Partner Content | Should Value Investors Pick Teva Pharmaceutical (TEVA) Now? Aug 16 / Zacks.com - Paid Partner Content |
| Endo Up on Settlement of a Few Cases Related to Opioid Drugs Aug 21 / Zacks.com - Paid Partner Content | Jazz (JAZZ) Acquires Cavion, Adds Movement Disorder Candidate Aug 13 / Zacks.com - Paid Partner Content |
| Teva Launches Generic Version of Mylan's EpiPen for KIds Aug 21 / Zacks.com - Paid Partner Content | 5 Top Value Stocks to Buy Now Aug 13 / MotleyFool.com - Paid Partner Content |
| 3 Warren Buffett Stocks to Buy Right Now Aug 21 / MotleyFool.com - Paid Partner Content | BioDelivery (BDSI) Earnings & Sales Beat Estimates in Q2 Aug 09 / Zacks.com - Paid Partner Content |
| Previous close | 7.45 |
| Today’s open | 7.48 |
| Day’s range | 7.13 - 7.55 |
| Volume | 13,692,252 |
| Average volume (3 months) | 19,191,589 |
| Market cap | $6.8B |
| Earnings growth (last year) | +85.71% |
| Earnings growth (this year) | -18.73% |
| Earnings growth (next 5 years) | +2.20% |
| Revenue growth (last year) | -16.69% |
| P/E ratio | NM |
| Price/Sales | 0.84 |
| Price/Book | 0.46 |
| Today’s change | Today’s % change | |
|---|---|---|
| BGNEBeiGene Ltd | -2.10 | -1.44% |
| BBIOBridgeBio Pharma Inc | -0.02 | -0.07% |
| AKRXAkorn Inc | +0.03 | +1.11% |
| OASMYOasmia Pharmaceutica... | -0.05 | -3.23% |
| Next reporting date | November 1, 2019 |
| EPS forecast (this quarter) | $0.58 |
| Annual revenue (last year) | $18.8B |
| Annual profit (last year) | -$2.1B |
| Net profit margin | -11.40% |
Sector Health Technology |
Industry Pharmaceuticals: Generic |
President, Chief Executive Officer & Director Kåre Schultz |
Executive Vice President- Global Operations Carlo de Notaristefani |
Corporate headquarters Petach Tikva, Hamerkaz |
